Parametric Portfolio Associates’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Parametric Portfolio Associates’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,810	Closed	-$26K	–	3702
2021 Q2	$26K	Buy	+15,810	New	+$26.4K	﹤0.01%	3556
2019 Q2	–	Sell	-12,792	Closed	-$20K	–	4016
2019 Q1	$20K	Buy	+12,792	New	+$19.5K	﹤0.01%	3913
2018 Q4	–	Sell	-40,303	Closed	-$74K	–	3990
2018 Q3	$74K	Buy	+40,303	New	+$78.2K	﹤0.01%	3881
2015 Q3	–	Sell	-48,904	Closed	-$97K	–	3358
2015 Q2	$97K	Sell	48,904 -62,126	-56%	-$176K	﹤0.01%	3881
2015 Q1	$430K	Buy	111,030 +8,213	+8%	+$30.4K	﹤0.01%	3357
2014 Q4	$371K	Buy	102,817 +73,208	+247%	+$194K	﹤0.01%	3432
2014 Q3	$79K	Buy	+29,609	New	+$198K	﹤0.01%	3747

Other funds holding MBII

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parametric Portfolio Associates's MBII Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2021, closing a stake of 15,810 shares — an estimated $26K sold.

Parametric Portfolio Associates first reported a position in MBII in Q3 2014 and held it in 7 quarters. The position peaked at $430K in Q1 2015. 73 funds tracked by Wall St. Rank hold MBII as of Q3 2021.

Parametric Portfolio Associates reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 15,810 Marrone Bio Innovations, Inc. shares in Q3 2021, an estimated $26K.
Parametric Portfolio Associates first reported a position in Marrone Bio Innovations, Inc. in Q3 2014 and held it in 7 quarters.
Parametric Portfolio Associates's Marrone Bio Innovations, Inc. position peaked at $430K in Q1 2015.
73 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.